Ladprao General Hospital PCLBKK:LPH 80 EBITDA Margin % is 16.87% as of Mar. 2026, which is 6% below its 10-year median of 17.95. GuruFocus rates BKK:LPH with a GF Score™ of 80/100 and a GF Value™ of ฿4.72 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Ladprao General Hospital PCL ranks better than 71.11% on this metric.
Ladprao General Hospital PCL (BKK:LPH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ladprao General Hospital PCL EBITDA Margin % Related Terms
Ladprao General Hospital PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ladprao General Hospital PCL EBITDA Margin % Chart
BKK:LPH vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ladprao General Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ladprao General Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ladprao General Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ladprao General Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ladprao General Hospital PCL (BKK:LPH) has a EBITDA Margin % of 16.87% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ladprao General Hospital PCL and its competitors. This is near median its historical median of 17.95. Over the past decade, Ladprao General Hospital PCL's EBITDA Margin % has ranged from 13.32 to 29.43. According to the industry distribution chart, Ladprao General Hospital PCL ranks #193 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 28.9%.
Is Ladprao General Hospital PCL's EBITDA Margin % too high?
Ladprao General Hospital PCL's current EBITDA Margin % of 16.87% is near median its 10-year median of 17.95. Over the past 10 years, this metric has ranged from a low of 13.32 to a high of 29.43. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Ladprao General Hospital PCL's value of 16.87% is 65.2% above this industry median. Based on the distribution chart, Ladprao General Hospital PCL ranks #193 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ladprao General Hospital PCL has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ladprao General Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ladprao General Hospital PCL ranks #193 out of 668 companies for EBITDA Margin %. This puts Ladprao General Hospital PCL in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Ladprao General Hospital PCL's value of 16.87% is 65.2% above this benchmark. Historically, Ladprao General Hospital PCL's own EBITDA Margin % has ranged from 13.32 to 29.43 over the past decade. While the company's 10-year median is 17.95 vs. the industry median of 10.21, Ladprao General Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ladprao General Hospital PCL's current EBITDA Margin % of 16.87% is 65.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ladprao General Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ladprao General Hospital PCL's current EBITDA Margin % is 16.87%, which is near median its own 10-year median of 17.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ladprao General Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ladprao General Hospital PCL (BKK:LPH) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿4.72, compared to a current price of ฿3.50 — trading 25.8% below its estimated fair value. The current EBITDA Margin % is 16.87%, which is near median its 10-year median of 17.95 and 65.2% above the Healthcare Providers & Services industry median of 10.21. Ladprao General Hospital PCL's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ladprao General Hospital PCL (BKK:LPH), the current EBITDA Margin % is 16.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ladprao General Hospital PCL (BKK:LPH) Overvalued in 2026?
Based on GuruFocus' analysis, Ladprao General Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.50 is trading 25.8% below its estimated GF Value™ of ฿4.72.
GuruFocus considers Ladprao General Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:LPH:
EBITDA Margin %: 16.87% (near median its 10-year median of 17.95)
GF Value™: ฿4.72 vs. price of ฿3.50 (25.8% below fair value)
Industry Position: 65.2% above the Healthcare Providers & Services median (#193 of 668)
No single metric tells the full story. See the BKK:LPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ladprao General Hospital PCL is principally engaged in the hospital business. It has two segments: Hospital, and Scientific testing &, Inspection & Quality System Certification. The Hospital segment includes hospital services, health care centers, and a service contract with the Social Security Office. The Scientific Testing & Inspection & Quality System Certification segment provides analytical and diagnostic services for food and agricultural, pharmaceutical, and environmental, covering product analysis, calibration of instruments, inspections, and certifications in accordance with quality systems and international standards. A majority of its revenue is generated from the Hospital segment. The company mainly operates in Thailand.
80GF Score
Get the complete analysis for BKK:LPH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:LPH has been successfully added to your 
